|
combination of Trilaciclib and Pemetrexed Clinical Trials
0 actively recruiting trials
Also known as: CDK 4/6 inhibitor, G1T28
No trials match the selected filters.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.